Alector
We are on a mission to make brain disorders history.
141 employees · est. 2013 · South San Francisco, United...
Lys Therapeutics
First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration.
13 employees · est. 2021 · Lyon, France
Alector is the older company (2013 vs 2021); Alector is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Alector | Lys Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2021 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Lyon, France |
| Employees | ||
| Employees | 141 larger | 13 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | IPO | Non Equity Assistance |
| Total Funding | ||
| Total Funding | $495.50M | $6.10M |
| Funding Rounds | ||
| Funding Rounds | 8 | 5 |
| Services | ||
| Services | Development of therapies for neurodegenerative diseases, Conducting clinical trials, Research in human genetics, neuroscience, and immunology | Development and commercialization of biotherapies for neurological diseases |
| Target Customers | ||
| Target Customers | Patients with neurodegenerative diseases, Healthcare providers, Research institutions | Patients suffering from neurological diseases, healthcare professionals, pharmaceutical companies, research institutions |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Diseases, Clinical Development, Antibody Discovery, Protein Engineering, Blood-Brain Barrier Technology, Alzheimer's Disease, Neuroimmunology, Genetic Targeting, Therapeutic Development, Neuroscience, Innovative Therapies, Drug Development, Lysosomal Dysfunction, Immune System Restoration | Neurodegenerative Disorders, Biotherapies, Neuroinflammation, Blood-brain Barrier, Monoclonal Antibody, Drug Development, Neurovascular Diseases, NMDA Receptors, Tight Junctions, Endothelial Cells, Excitotoxicity, Stroke, Multiple Sclerosis, Parkinson's Disease |
| Website | ||
| Website | alector.com | lystherapeutics.com |
About Alector
Alector, founded in 2013 and headquartered in the United States, is a cutting-edge player in the Biotechnology sector, focused on transforming approaches to Health Care and Pharmaceuticals. With the bold mission "to make brain disorders history," Alector is anchored in a late-stage clinical phase wi...
About Lys Therapeutics
Lys Therapeutics is a pioneering biotechnology company founded in 2021 with headquarters in France. The company's slogan, "First-in-class biotherapies against neurological diseases," encapsulates its primary focus on targeting blood-brain barrier (BBB) dysfunctions and neuroinflammation to revolutio...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Alector and Lys Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Alector and Lys Therapeutics — by email.
Frequently Asked Questions
Compare Alector with someone else
Start typing a company name or domain.